Welch Allyn, a medical device manufacturer and key employer in central New York, will be acquired by Chicago-based Hill-Rom.
The news was first announced by both companies Wednesday morning. Hill-Rom and Welch Allyn's boards of directors have approved the agreement. And Hill-Rom President and CEO John Greisch will continue to hold both positions with the new combined company.
Here is a look at Hill-Rom's acquisition of Welch Allyn, by the numbers:
$2,050,000,000: The amount Hill-Rom will pay to acquire Welch Allyn. The transaction is expected to be finalized by the end of September.
$1,625,000,000: How much Welch Allyn shareholders will receive in cash payments after the sale is completed. Shareholders will also receive approximately 8.1 million in newly-issued shares of Hill-Rom common stock, according to a news release.
75 (approximately). The number of Welch Allyn shareholders. Once the transaction is completed, these shareholders will own roughly 13 percent of the combined company.
$2,600,000,000. The total revenues Hill-Rom expects the combined company to have once the transaction is finalized. The combined company will also generate more than $500 million in earnings before interest, taxes, depreciation and amortization.
$40,000,000. Hill-Rom projects that annual run-rate cost savings will reach at least $40 million by 2018. The company believes it can achieve this by facility optimization, procurement efficiencies and administrative expense reductions.
10 percent. Hill-Rom says that the transaction will be more than 10 percent accretive to adjusted earnings per share in 2016 and "meaningfully more accretive thereafter."
10,000. The number of employees the combined company will have, according to a news release.
2,600. The current number of Welch Allyn employees. Welch Allyn has locations in 26 countries, including corporate headquarters in Skaneateles Falls.
30. With Hill-Rom's acquisition of Welch Allyn, the combined company will have operations in more than 30 countries.
100. Number of years Welch Allyn has been in operation. The privately-held company was founded in 1915 by Dr. Francis Welch and William Noah Allyn.